Pioglitazone may offer therapeutic advantages in diabetes-related atrial fibrillation.

Changle Liu,Tong Liu,Guangping Li
DOI: https://doi.org/10.1016/j.ijcard.2013.01.037
IF: 4.039
2013-09-30
International Journal of Cardiology
Abstract:
What problem does this paper attempt to address?